Three Analysts Reaffirm Buy on CrowdStrike With Higher Price Targets Despite 5.79% Selloff
By TrendSpider Editor
CrowdStrike Holdings, Inc. is under significant selling pressure Wednesday, dropping 5.79% to $200.59, even as three Wall Street firms simultaneously confirmed buy ratings and raised their price targets on the cybersecurity giant. Barclays, Benchmark, and TD Cowen all lifted their targets, with the
Three Analysts Reaffirm Buy on CrowdStrike With Higher Price Targets Despite 5.79% Selloff
CrowdStrike Holdings, Inc. is under significant selling pressure Wednesday, dropping 5.79% to $200.59, even as three Wall Street firms simultaneously confirmed buy ratings and raised their price targets on the cybersecurity giant. Barclays, Benchmark, and TD Cowen all lifted their targets, with the average across the three sitting at $240, implying meaningful upside from current levels. Despite today's slide, CRWD continues to trade near the upper half of its 52-week range of $85.68 to $227.50, underscoring how far the stock has traveled over the past year.
Key Drivers of the CRWD Stock Move
- Main Catalyst: Three analysts reaffirmed buy ratings on CRWD in a single session. Barclays raised its price target from $169 to $235, TD Cowen moved its target from $175 to $235, and Benchmark lifted its target from $230 to $250. Despite the positive analyst sentiment, the stock sold off 5.79%, suggesting broader market pressure or profit-taking overwhelmed the bullish research notes.
- Bull Case: All three firms maintained buy-equivalent ratings, and the average price target of $240 represents roughly 19.7% upside from the current price of $200.59. The largest target revision came from TD Cowen, which raised its price target by $60, signaling a significant increase in conviction. Benchmark's $250 target is the most aggressive of the three and sits closest to the 52-week high of $227.50.
- Bear Case: The fact that three confirmed buy ratings with raised targets failed to halt a nearly 6% decline raises questions about broader selling pressure or negative news not reflected in analyst commentary. The stock is now trading meaningfully below all three price targets, and if sentiment deteriorates further, a retest of lower levels within the 52-week range cannot be ruled out given the wide band between $85.68 and $227.50.
The forward setup for CRWD is a study in contradictions. Analyst conviction is clearly building, as evidenced by the coordinated target increases from Barclays, Benchmark, and TD Cowen, yet the tape is telling a different story on Wednesday. When multiple analysts raise targets on the same day and a stock still falls nearly 6%, it often signals that institutional sellers are driving price action independently of sell-side research. Investors will want to watch whether today's decline finds support in the $195 to $200 range or accelerates lower. With the 52-week high at $227.50 and the consensus average target at $240, the bull thesis remains intact on paper, but price action will ultimately arbitrate between analyst optimism and market reality in the sessions ahead.
CRWD Analyst Ratings and Price Targets
Three separate analyst actions were logged on Wednesday, all confirming existing buy-equivalent ratings while raising price targets:
- Barclays (Saket Kalia): Confirms Buy | Price target raised to $235 from $169
- Benchmark (Yi Fu Lee): Confirms Buy | Price target raised to $250 from $230
- TD Cowen (Shaul Eyal): Confirms Buy | Price target raised to $235 from $175
The consensus rating across all three actions is Buy, with an average price target of $240. The target range spans $235 on the low end, shared by Barclays and TD Cowen, to $250 on the high end from Benchmark. Notably, zero downgrades and zero upgrades were recorded today, meaning all activity reflects affirmations of existing positive stances rather than directional rating changes.
CRWD Seasonality
Mid-to-late August has historically been a mixed period for technology and cybersecurity names, as institutional activity around back-to-school seasonal repositioning and pre-Labor Day volume drops can exaggerate single-session moves in either direction. Wednesday's sharp decline on positive analyst news may reflect this thinner liquidity environment more than a fundamental shift in the CRWD investment thesis.
CRWD Relative Performance
CrowdStrike's 5.79% decline on Wednesday stands out as a notable underperformer relative to the broader technology sector on a day featuring uniform analyst affirmations. Trading at $200.59, the stock sits well below its 52-week high of $227.50 but dramatically above the 52-week low of $85.68, reflecting a recovery arc that has rewarded longer-term holders. The divergence between analyst price targets averaging $240 and the current market price of $200.59 represents a gap of approximately $39.41, a spread that the market has so far declined to close despite Wednesday's positive research activity.
More on CRWD
- CrowdStrike Tumbles 5.36% as Shares Slide to $190.83 Amid Broad Selloff
- CrowdStrike Surges to Within Striking Distance of Its 52-Week High as Momentum Builds
- CrowdStrike Hovers Just Below Its 52-Week High as Momentum Holds Near $225
- CrowdStrike Surges 2.14% to Touch Its 52-Week High Zone at $219
- CrowdStrike Surges 6.07% to $202.44, Approaching Its 52-Week High
Latest Market News
- Procter & Gamble Slides 1.05% as Stock Hovers Near 52-Week Low
- ARM Holdings Sees $3.6M in Unusual Call Activity as Stock Trades Near Midpoint of 52-Week Range
- Microsoft Stock Flags Bearish Signal as $1.99M Put Sweep Targets $480 Strike Into January 2027
- Merck Scores Morgan Stanley Upgrade to Buy With $179 Target as RBC Cuts to Hold
- AbbVie Stock Pulls Back 1.15% But Holds Near 52-Week High of $267.47
- Coca-Cola Stock Clears 52-Week High at $91.20, Signaling Fresh Bullish Momentum